Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China · Delayed Price · Currency is CNY 22.96
+0.73 (3.28%)
Sep 30, 2026, 3:04 PM CST
SHE:002940 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 548.34 | 687.41 | 697.38 | 859.75 | 735.47 | 688.91 |
Trading Asset Securities | 286.5 | 102.26 | 36.04 | 10 | 69.3 | 59.6 |
Cash & Short-Term Investments | 834.84 | 789.67 | 733.42 | 869.75 | 804.76 | 748.51 |
Cash Growth | 5.97% | 7.67% | -15.68% | 8.08% | 7.52% | -12.36% |
Accounts Receivable | 155.09 | 218.89 | 234.32 | 244.86 | 295.51 | 301.32 |
Other Receivables | 7.91 | 8.24 | 9.85 | 21.45 | 6.77 | 17.27 |
Receivables | 163.01 | 227.13 | 244.18 | 266.31 | 302.28 | 318.59 |
Inventory | 520.41 | 447.47 | 503.79 | 393.44 | 293.23 | 299.6 |
Other Current Assets | 18.87 | 21.58 | 17.48 | 32.43 | 51.69 | 9.25 |
Total Current Assets | 1,537 | 1,486 | 1,499 | 1,562 | 1,452 | 1,376 |
Property, Plant & Equipment | 608.51 | 617.28 | 603.86 | 615.8 | 445.7 | 474.63 |
Long-Term Investments | 287.56 | 304.84 | 304.7 | 301.41 | 302.15 | 147.34 |
Goodwill | 312.94 | 312.94 | 312.94 | 312.94 | 21.98 | 21.98 |
Other Intangible Assets | 119.11 | 123.57 | 133.55 | 139.14 | 38.78 | 40.05 |
Long-Term Deferred Tax Assets | 35.64 | 39.12 | 50.06 | 32.77 | 22.44 | 20.65 |
Long-Term Deferred Charges | 52.28 | 52.64 | 49.48 | 35.06 | 0.98 | 1.6 |
Other Long-Term Assets | 22.73 | 14.57 | 21.07 | 20.95 | 312.09 | 1.36 |
Total Assets | 2,976 | 2,951 | 2,975 | 3,020 | 2,596 | 2,084 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 458.15 | 434.09 | 485.45 | 402.49 | 320.45 | 335.97 |
Accrued Expenses | 68.71 | 94.34 | 120.24 | 130.41 | 220.56 | 218.67 |
Short-Term Debt | 135.38 | 142.42 | 163.37 | 134.9 | 171.94 | 1.76 |
Current Portion of Long-Term Debt | 8.94 | 69.74 | 20.21 | 30.4 | 25.02 | - |
Current Portion of Leases | - | - | - | 0.26 | - | - |
Current Income Taxes Payable | 0.76 | 3.8 | 5.57 | 9.34 | - | 2.88 |
Current Unearned Revenue | 45.78 | 23.92 | 32.31 | 18.72 | 41.67 | 31.9 |
Other Current Liabilities | 55.15 | 44.73 | 16.39 | 5.45 | 8.95 | 4.1 |
Total Current Liabilities | 772.87 | 813.03 | 843.54 | 731.97 | 788.59 | 595.29 |
Long-Term Debt | 272.33 | 242.26 | 303.5 | 423.95 | 150 | - |
Long-Term Unearned Revenue | 18.36 | 17.64 | 16.78 | 17.85 | 9.73 | 13.3 |
Long-Term Deferred Tax Liabilities | 10.32 | 10.67 | 12.29 | 13.95 | 1.6 | 0.06 |
Total Liabilities | 1,074 | 1,084 | 1,176 | 1,188 | 949.93 | 608.64 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 201.73 | 201.73 | 201.73 | 201.73 | 139.12 | 95.95 |
Additional Paid-In Capital | 708.14 | 708.28 | 684.01 | 723.84 | 782.91 | 824.87 |
Retained Earnings | 819.73 | 794.22 | 712.9 | 674.51 | 577.87 | 478.74 |
Treasury Stock | -84.1 | -84.1 | -74.5 | -20.12 | - | -63.34 |
Comprehensive Income & Other | 9.2 | 7.15 | 6.4 | 6.25 | 2.75 | 2.64 |
Total Common Equity | 1,655 | 1,627 | 1,531 | 1,586 | 1,503 | 1,339 |
Minority Interest | 247.32 | 239.94 | 267.87 | 246.07 | 143.5 | 136.08 |
Shareholders' Equity | 1,902 | 1,867 | 1,798 | 1,832 | 1,646 | 1,475 |
Total Liabilities & Equity | 2,976 | 2,951 | 2,975 | 3,020 | 2,596 | 2,084 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 416.65 | 454.42 | 487.08 | 589.52 | 346.96 | 1.76 |
Net Cash (Debt) | 418.19 | 335.25 | 246.34 | 280.23 | 457.8 | 746.75 |
Net Cash Growth | 46.59% | 36.09% | -12.10% | -38.79% | -38.69% | -11.34% |
Net Cash Per Share | 2.05 | 1.66 | 1.23 | 1.40 | 2.30 | 3.74 |
Filing Date Shares Outstanding | 196.11 | 196.11 | 196.89 | 199.71 | 197.4 | 197.4 |
Total Common Shares Outstanding | 196.11 | 196.11 | 196.89 | 199.71 | 197.4 | 197.4 |
Working Capital | 764.26 | 672.82 | 655.33 | 829.96 | 663.37 | 780.67 |
Book Value Per Share | 8.44 | 8.30 | 7.77 | 7.94 | 7.61 | 6.78 |
Tangible Book Value | 1,223 | 1,191 | 1,084 | 1,134 | 1,442 | 1,277 |
Tangible Book Value Per Share | 6.23 | 6.07 | 5.51 | 5.68 | 7.30 | 6.47 |
Buildings | 456.48 | 453.09 | 447.5 | 435.42 | 314.48 | 319.46 |
Machinery | 669.6 | 677.06 | 640.01 | 628.95 | 467.67 | 439.73 |
Construction In Progress | 86.83 | 79.75 | 49.6 | 22.52 | 25.33 | 29.94 |